FeNO testing for suspected asthma patients

FeNO (Fractional exhaled Nitric Oxide) testing alongside the recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of the asthma population, are wrongly diagnosed and given inappropriate medication. Our project will look to reduce the use of steroids and improve diagnosis, enabling correct adjustments or the right medication to be prescribed. FeNO is indicative of the severity of airway inflammation.

Project overview

Our aim is to support the adoption of FeNo testing thought England and our HIN members in South London. Success will be seeing an improvement in rapid accurate diagnosis and appropriate prescribing and further supporting patients who respond poorly to steroids. The AAC project will be supported by Asthma UK and the British Lung Foundation Partnership with patient and public involvement. The project commenced in November 2020 and will run for two years. The HIN is actively providing project support in the adoption and roll out of FeNO testing equipment and associated recommended processes for patient identification and management towards GP practices. This will also include support towards primary care networks (PCNs) and asthma hubs based upon eligibility prescribed within the project scope provided by NHSE.

We will look to review your current diagnostic process and explain current best practice and new training being made available. Participants will be able to bid for pathway transformation funding in January 2021.

We're here to help

Please contact us if you are interested in taking part.

Email the team